News
The Mason Capital fund, which owns 3.174% of Grifols' (GRF) class A shares, has expressed its support for the blood products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback